Latent Mycobacterium tuberculosis Infection in liver transplant recipients-Controversies in current diagnosis and management

Journal of Clinical and Experimental Hepatology

Volumn 1, Issue 1, 2011, Pages 34-37

  Rajagopala, Srinivas ^a   Olithselvan, A ^a   Varghese, Joy ^a   Shanmugam, Naresh ^a   Rela, Mohamed ^a  

^a Global Hospitals   (India)

Author keywords

Isoniazid prophylaxis; Latent tuberculosis infection; Liver transplantation; Solid organ transplantation; Tuberculosis

Indexed keywords

GAMMA INTERFERON; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAPENTINE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE DEFICIENCY; INDIA; LATENT TUBERCULOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PATIENT COMPLIANCE; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; TOXIC HEPATITIS; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

EID: 83455212081     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/S0973-6883(11)60120-5     Document Type: Article

References (30)

1. Kakodkar R, Soin A, Nundy S Liver transplantation in India: its evolution, problems and the way forward. The National Medical Journal of India 2007, 20:53-56.
2. Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009, 15:894-906.
3. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solidorgan transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009, 48:1276-1284.
4. Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002, 74:1381-1386.
5. Hsu MS, Wang JL, Ko WJ, et al. Clinical features and outcome of tuberculosis in solid organ transplant recipients. Am J Med Sci 2007, 334:106-110.
6. Clemente WT, Faria LC, Lima SS, et al. Tuberculosis in liver transplant recipients: a single Brazilian center experience. Transplantation 2009, 87:397-401.
7. Higgins RSD, Kusne S, Reyes J, Yousem S, Gordon R, Thiel DV Mycobacterium tuberculosis after liver transplantation: management and guidelines for prevention. Clin Transplant 1992, 6:81-90.
8. Singh N, Paterson DL Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998, 27:1266-1277.
9. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK Risk factors for post-transplant tuberculosis. Kidney Int 2001, 60:1148-1153.
10. Naqvi A, Rizvi A, Hussain Z, et al. Developing world perspective of posttransplant tuberculosis: morbidity, mortality, and cost implications. Transplant Proc 2001, 33:1787-1788.
11. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004, 10:886-897.
12. Naqvi SA The challenge of posttransplant tuberculosis. Transplant Proc 2000, 32:650-651.
13. Revised National Tuberculosis Control Programme-technical and operational guidelines for tuberculosis control. [updated 2005, 10.4.2007] http://www.tbcindia.org/pdfs/Technical%20&%20Operational%20guidelines%20for%20TB%20Control.pdf.
14. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996, 61:211-215.
15. Agarwal SK, Gupta S, Bhowmik D, Mahajan S Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: a single center study. Indian J Nephrol 2010, 20:132-136.
16. Munoz P, Rodriguez C, Bouza E Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005, 40:581-587.
17. Christopher DJ, Daley P, Armstrong L, et al. Tuberculosis infection among young nursing trainees in South India. PLoS One 2010, 5:e10408.
18. Pai M, Kalantri S, Aggarwal AN, Menzies D, Blumberg HM Nosocomial tuberculosis in India. Emerg Infect Dis 2006, 12:1311-1318.
19. Maher D The natural history of Mycobacterium tuberculosis infection in adults. Tuberculosis: A Comprehensive Clinical Reference 2009, 129-132. Elsevier Saunders. H.S. Schaaf, A. Zumla (Eds.).
20. Torre-Cisneros J, Caston JJ, Moreno J, et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004, 77:1376-1380.
21. Agoglia L, Balbi E, Halpern M, et al. Tuberculosis in liver transplant recipients: prophylaxis in an endemic area. Transplant Proc 2011, 43:199-202.
22. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009, 48:1657-1665.
23. Manuel O, Humar A, Preiksaitis J, et al. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007, 7:2797-2801.
24. Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011, 37:100-111.
25. Codeluppi M, Cocchi S, Guaraldi G, et al. Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant Proc 2006, 38:1083-1085.
26. American Thoracic Society/Centers for Disease Control and Prevention Targeted testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000, 161:S221-S247.
27. Currie AC, Knight SR, Morris PJ Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Transplantation 2010, 90:695-704.
28. Wang X, Zhuang J, Xie L, Li M, Lu Y Isoniazid preventive therapy for post-renal transplant tuberculosis: a systematic review. Reviews in Medical Microbiology 2011, 22:5-11.
29. John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JC A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994, 57:1683-1684.
30. Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004, 36:425-431.